Udayavni Special

Paediatric trials of Covaxin may begin in June: Bharat Biotech official


PTI, May 24, 2021, 7:04 PM IST

Hyderabad: Bharath Biotech may start clinical trials of its COVID-19 vaccine Covaxin on children from June, a senior official of the vaccine-maker has said. Raches Ella, Head-Business Development and International Advocacy of Bharath Biotech, recently in a virtual conversation with members of FICCI Ladies Organisation (FLO), Hyderabad, on “All About Vaccines”, said no vaccine offers 100 per cent protection.

The efficacy of the jab can be improved upto 100 per cent protection by the COVID-19 appropriate behaviour and following other safety protocols, he said. Bharath Biotech has received permission to carry out paediatric trials of the vaccine and it may commence trials from June 1, he said.

It would be a trial on children aged 2-18 years for which Bharath Biotech may get the licence in the third quarter of this year, a press release from FLO quoted Ella as saying on Sunday. A few side-effects of vaccination are common and they shouldnt deter anyone from taking the jab, he further said.

I am happy that our hard work is paying off well as the vaccine is working well and saving lives. We have this good feeling when we go back home from work each day. We will be soon ramping up our manufacturing capacity to 700 million doses by the end of this year, he said replying to a query.

According to him, the success probability of a vaccine is just 6 per cent from discovery to development and it would take seven to 10 years to come out with a jab. Presently pregnant and lactating mothers, special population and kids are not allowed to be given vaccines. Once separate clinical trials are done on these groups and proved effective then they may be allowed to be inoculated, he said. Ella said the current vaccines are doing well enough but the requirement of a booster dose would depend on future variants of the virus.

Udayavani is now on Telegram. Click here to join our channel and stay updated with the latest news.

Top News

Delhi riots: Court defers order on ‘immediate release’ of student activists for Thursday

British PM forced to defend India travel ban timing over Delta variant in Parliament

Ambani bomb scare case: NIA seeks custody of former cop

COVID: At least half of judges should sit on alternate days to hear those in distress, says SC

No question of leadership change: Nalin Kumar Kateel

‘Two great powers’: 1st round of talks ends at Biden-Putin summit

Cong to undertake campaign to help Covid pandemic-affected people, gather data on deceased



Related Articles More

A fifth of asymptomatic covid patients develop ‘Long Covid’: study

Less than 1,000 new COVID-19 cases in Bengaluru for first time in 2 months

CSIR-IICT, Bengaluru pharma firm join hands to manufacture anti-COVID drug 2-DG

COVID-19 has created an ‘ecosystem’ of innovation in India: Kiran Mazumdar-Shaw

COVID-19: Karnataka logs 6,835 new cases, 120 deaths

MUST WATCH

Udayavani 16-JUN-2021 News Bulletin

100 % sure that I was targeted in drugs case, says Ragini Dwivedi

Baby Elephant Operates Hand Pump on Its Own to Drink Water

Suresh Shetty Gulme | Success Story of Modern Cow Dairy Farming | Kannada

Complete Guide on Mango Farming | Harvesting Techniques

Latest Additions

Delhi riots: Court defers order on ‘immediate release’ of student activists for Thursday

British PM forced to defend India travel ban timing over Delta variant in Parliament

Ambani bomb scare case: NIA seeks custody of former cop

COVID: At least half of judges should sit on alternate days to hear those in distress, says SC

No question of leadership change: Nalin Kumar Kateel

Thanks for visiting Udayavani

You seem to have an Ad Blocker on.
To continue reading, please turn it off or whitelist Udayavani.